Adenoviral-mediated gene transfer of a constitutively active retinoblastoma gene inhibits human pancreatic tumor cell proliferation

Surgery

Volumn 122, Issue 2, 1997, Pages 428-434

  Simeone, Diane M ^a,b   Cascarelli, Amy ^a   Logsdon, Craig D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0030875896     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90036-2     Document Type: Conference Paper

References (21)

1. Hahn SA, Kern SE. Molecular genetics of exocrine pancreatic neoplasms. Surg Clin North Am 1995;75:857-69.
2. Lees JA, Buchkovich KJ, Marchak DR, Anderson CW, Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by cdc2. EMBO J 1991;10:4279-90.
3. Yoshimura K, Rosenfeld MA, Seth P, Crystal RG. Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors. J Biol Chem 1994;268:2300-3.
4. Cotten M, Wagner E, Zatloukal K, Birnsteil M. Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J Virol 1993;67:3777-85.
5. Katayose D, Wersto R, Cowan KH, Seth P. Effects of recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ 1995;6:1207-12.
6. Brody SL, Jaffe HA, Han SK, Wersto RP, Crystal RG. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum Gene Ther 1994;5:437-47.
7. Chang MW, Barr E, Seltzer J, Jiang Y, Nabel GJ, Nabel EG, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995;267:518-22.
8. Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Hartman JW, Roessler BJ. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 1995;96:2454-60.
9. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, editor. Methods in molecular biology: gene transfer and expression protocols. Clifton (NJ): The Humana Press, Inc; 1991. p 109-28.
10. Riley DJ, Nikitin AY, Lee WH. Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotrph tumors in Rb+/- mice. Nat Med 1996;2:1316-21.
11. Foster R, Zhao X, Day K, Swanson P, Humphrey P, Dean D, et al. The retinoblastoma gene product mediates apoptosis of prostrate epithelium [abstract]. Proc Annu Meet Am Assoc Cancer Res 1996;37:A194.
12. Kaneko S, Hallenback P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995;55:5283-7.
13. Seth P, Brinkmann U, Schwartz GN, Katayose D, Gress R, Pastan I, et al. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res 1996;56:1346-51.
14. Hamada K, Ramon A, Zhang W, Hittelman W, Lotan R, Roth J, et al. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res 1996;56:3047-54.
15. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
16. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
17. Friend SH, Bernards R, Togelj S, Weinberg RA, Rapaport JM, Albert DM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:653-6.
18. Goodrich DW, Lee WH. Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta 1993;1155:43-61.
19. Zhou Y, Li J, Xu K, Hu S, Benedict WF, Xu HJ. Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Proc Natl Acad Sci USA 1994;91:4165-9.
20. Xu H, Zhou Y, Seigne J, Perng G, Mixon M, Zhang C, et al. Enhanced tumor supressor gene therapy via repication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res 1996;56:2245-9.
21. Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, et al. Molecular and immunochemical analyses of Rb1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Mol Carcinog 1996;15:85-95.